secwatch.observer — SEC 8-K summary
======================================

Issuer:     Strata Critical Medical, Inc. (SRTA)
CIK:        0001779128
Form:       8-K/A
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001104659-25-085182
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Strata Critical Medical appoints Co-CEOs Tomkiel and Heyburn, approves $550K salary and PSUs
--------------------------------------------------------------------------------

- Melissa Tomkiel and William Heyburn became Co-CEOs effective Aug 1, 2025, retaining General Counsel and CFO roles respectively.
- Base salary for each Co-CEO increased to $550,000, approved by the Board on Aug 27, 2025.
- Each received PSUs with target values: $500,000 based on Passenger business 12-month targets, and $2,000,000 on three-year company performance.
- On termination without cause or for good reason, unvested time-vesting equity vests up to 18 months; performance-vesting PSUs vest pro-rata with 548-day add-on.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1779128/000110465925085182/0001104659-25-085182-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1779128/000110465925085182/tm2524340d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-085182

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer